Autoimmune heparin-induced thrombocytopenia Advocacy Hub | UniteRare

At a Glance

Live from database

🩺

2Specialists

💰

1Open funds

Regulatory Watchboard

2 events

May 2024Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity

Hospices Civils de Lyon — NA

TrialACTIVE NOT RECRUITING

Nov 1997

Neumega: FDA approved

Prevention of severe chemotherapy-induced thrombocytopenia.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Neumega

Genetics Institute, Inc.

OpenContact for details

View all support programs on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Autoimmune heparin-induced thrombocytopenia.
Search all trials →

Search clinical trials for Autoimmune heparin-induced thrombocytopenia →

Recent News & Research

No recent news articles indexed yet for Autoimmune heparin-induced thrombocytopenia.
Search PubMed for Autoimmune heparin-induced thrombocytopenia →

Browse all Autoimmune heparin-induced thrombocytopenia news →

Specialist Network

Top 2 by expertise

John Alexander

Duke Clinical Research Institute

Score 01 trial

Pr Jérôme Honnorat, Pr

Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier Est

📍 Bron

Score 0

View all Autoimmune heparin-induced thrombocytopenia specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰